LENZ – lenz therapeutics, inc. (US:NASDAQ)
Stock Stats
News
LENZ Therapeutics: Speculative But Strong Buy [Seeking Alpha]
The Consensus EPS Estimates For LENZ Therapeutics, Inc. (NASDAQ:LENZ) Just Fell Dramatically [Yahoo! Finance]
Why Lenz Therapeutics Stock Plummeted by Almost 20% This Week [Yahoo! Finance]
LENZ Therapeutics: Q4 Results Highlight A Worrying Lack Of Market Demand (Rating Downgrade) [Seeking Alpha]
LENZ Therapeutics (LENZ) had its price target lowered by Citigroup Inc. from $52.00 to $26.00. They now have a "buy" rating on the stock.
Form SCHEDULE 13G LENZ Therapeutics, Inc. Filed by: Squarepoint Ops LLC
Form 4 LENZ Therapeutics, Inc. For: Mar 27 Filed by: Schimmelpennink Evert B.
Form 4 LENZ Therapeutics, Inc. For: Mar 27 Filed by: Chevallard Daniel R.
Form 4 LENZ Therapeutics, Inc. For: Mar 27 Filed by: George Jeffrey P.
Form S-8 LENZ Therapeutics, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.